Motivated researcher with strong experience in clonal hematopoiesis, tumor immunology (AML/MDS, solid tumor microenviroment, cancer metastasis), and therapeutic development. Skilled in experimental design, data analysis, and scientific writing. Highly collaborative team player known for adaptability and reliability. Strong communicator with focus on achieving research goals and contributing to impactful scientific discoveries that benefits patients.
Appointed as a TRIUMPH Postdoctoral Fellow at MD Anderson Cancer Center to lead research on novel immunoprevention strategies targeting breast cancer and metastatic progression
Investigated the preclinical rationale for combining bispecific T cell engagers with antibody-drug conjugates (ADCs) in the treatment of diffuse large B-cell lymphoma (DLBCL)
Joined Dr. James Mulloy’s lab as a short-term scholar to investigate MLL-fusion acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) using patient-derived xenograft (PDX) models for therapeutic evaluation.
Technically proficient in flow cytometry, CyTOF, CRISPR-based gene editing, RNA-seq, ChIP-seq Experienced in handling in vivo models, including preclinical studies using transgenic mice and patient-derived xenografts (PDX) Computational skills include data analysis and visualization using R and beginner-level Python, with a commitment to continuous learning in bioinformatics Proven ability to collaborate across multi-disciplines, project managing, and communicate findings effectively through scientific writing and presentations